A new noninvasive test for colorectal cancer screening has been developed and validated and is now available for routine use. Gastroenterology nurses and assistants need to be aware of the stool deoxyribose nucleic acid test. This presentation describes this test and compares and contrasts it to other colorectal cancer screening modalities.

The stool deoxyribose nucleic acid test allows a "total colon" examination, is safe, noninvasive, and requires no prep, diet, or medication change. The stool deoxyribose nucleic acid test uses a single stool sample collected at home and sent to a central lab. This test works because advanced polyps and colorectal cancer are associated with deoxyribose nucleic acid test alterations that are known and that shed into the stool. By testing stool for these alterations, high sensitivity is achieved. In a recent study, stool deoxyribose nucleic acid test was four times as sensitive as three stools for occult blood.

Patients preferred the stool deoxyribose nucleic acid test to occult blood testing and colonoscopy. The stool deoxyribose nucleic acid test is cost effective. While not as accurate as colonoscopy, a stool deoxyribose nucleic acid test is the best noninvasive test for colorectal cancer screening. Stool deoxyribose nucleic acid test is useful for those who can't get colonoscopy or who wish a simpler test.

Section Description

We are pleased to present the Abstracts from the SGNA's 32nd Annual Course: Passion for GI Nursing: Pass It On!! The diversity of these topics certainly reflects the richness and breadth of our specialty. In keeping with the tradition of the Annual Course, we hope the following abstracts will encourage discussions for improving nursing practice and patient care outcomes.